Testosterone replacement therapy can reduce joint pain in men with low testosterone, though the effect is tied more to correcting a hormonal deficiency than to treating arthritis directly. In one long-term study of men with clinically low testosterone, 58% reported joint pain at the start of treatment. After nine months on TRT, that number dropped to 22%, and by the end of the five-year study period, just 1% still reported joint pain.
That’s a striking improvement, but it comes with important context. The men in that study had diagnosed hypogonadism, meaning their bodies weren’t producing enough testosterone on their own. Whether TRT would help someone with normal testosterone levels and arthritis is a different question, and the answer is far less clear.
How Testosterone Affects Inflammation
Testosterone is genuinely anti-inflammatory. It suppresses several of the key inflammatory molecules that drive joint pain and cartilage breakdown, including TNF-alpha, IL-6, and IL-1 beta. These aren’t obscure lab markers. They’re the same inflammatory signals targeted by many modern arthritis medications. When researchers gave testosterone to men with low levels and then stopped treatment, those inflammatory markers climbed right back up, confirming that testosterone was actively keeping them in check.
The mechanism works partly through fat tissue. Testosterone limits fat cell growth and reduces the inflammatory chemicals that fat cells release. Since excess body fat is itself a source of chronic low-grade inflammation, keeping fat tissue in check has a downstream benefit for joints. Testosterone also lowers C-reactive protein, a broad marker of systemic inflammation that tends to be elevated in people with both osteoarthritis and rheumatoid arthritis.
Testosterone’s Direct Role in Cartilage
Joint cartilage cells have androgen receptors, meaning they can respond directly to testosterone. Lab research has shown that activating these receptors in cartilage cells promotes the production of collagen and other structural molecules that keep cartilage healthy. At the same time, it reduces MMP-13, an enzyme that breaks cartilage down. Androgen receptor activation also lowers the rate at which cartilage cells die off, which matters because cartilage has very limited ability to regenerate once lost.
This doesn’t mean testosterone can rebuild a worn-out knee joint. But it suggests that adequate testosterone levels play a role in maintaining the cartilage you still have, particularly in slowing the kind of cellular breakdown that accelerates osteoarthritis.
The Osteoarthritis Picture
The clinical evidence for TRT and osteoarthritis is more complicated than the inflammation data alone would suggest. A large genetic analysis published in BMC Musculoskeletal Disorders found that higher bioavailable testosterone levels were actually associated with a slightly increased risk of developing osteoarthritis. The effect was small (an odds ratio of 1.01) but statistically significant, and the reverse wasn’t true: having osteoarthritis didn’t affect testosterone levels.
This seems to contradict the anti-inflammatory story, but the two findings aren’t necessarily in conflict. Testosterone also increases muscle mass and physical activity levels, which could mean more mechanical load on joints over a lifetime. It’s also possible that the genetic analysis captures a population-wide trend that doesn’t apply to men who are specifically deficient. The men who showed dramatic joint pain relief on TRT started with abnormally low testosterone. Correcting a deficiency is biologically different from boosting already-normal levels.
Rheumatoid Arthritis and Low Testosterone
Men with rheumatoid arthritis are far more likely to have low testosterone than healthy men. In one study of 104 men with RA, about 32% were hypogonadal, compared to just 7% of the healthy control group. This isn’t a coincidence. Rheumatoid arthritis is an autoimmune disease, and testosterone has broad immunosuppressive properties. It dampens the activity of immune cells called macrophages, influences how T-cells behave, and appears to reduce the production of antibodies that attack the body’s own joint tissue.
Animal research has shown that testosterone modifies the production of anti-citrullinated protein antibodies, which are a hallmark of rheumatoid arthritis and directly involved in joint destruction. Male mice without functioning testes developed more severe arthritis than intact males, and the difference tracked with antibody levels. This helps explain why RA is two to three times more common in women than men and why it often worsens in men as testosterone declines with age.
None of this means TRT is a treatment for rheumatoid arthritis. But for men with RA who also have confirmed low testosterone, restoring normal levels could address one contributing factor in their disease activity.
Bone Density Benefits
Arthritis and bone loss often go hand in hand, especially in men with low testosterone. TRT has well-documented effects on bone health. In men with hypogonadism, testosterone treatment increases bone mineral density in the spine and hip, improves the internal architecture of bone tissue, and increases estimated bone strength. These effects have been confirmed across multiple imaging methods and in studies lasting one to three years. Stronger bones don’t fix arthritis, but they reduce fracture risk in joints already weakened by cartilage loss and inflammation.
Side Effects That Can Affect Joints
TRT causes mild fluid retention in some men, which can lead to peripheral edema, or swelling in the hands, feet, and ankles. For someone already dealing with joint stiffness and swelling from arthritis, this side effect could temporarily make symptoms feel worse rather than better. The degree of retention is generally mild, but it’s worth knowing about, especially in the first weeks of treatment before the body adjusts.
Other side effects like increased red blood cell production require regular monitoring through blood work. These don’t directly affect joints but are part of the overall risk calculus when considering TRT for any reason.
Who Is Most Likely to Benefit
The strongest case for TRT helping with arthritis symptoms exists in men who have both confirmed low testosterone and joint pain. In that group, the evidence for reduced inflammation, lower pain scores, and improved quality of life is consistent. The five-year study showing joint pain dropping from 58% to 1% is the most compelling data point, though it studied reported joint pain broadly rather than diagnosed osteoarthritis specifically.
For men with normal testosterone levels and arthritis, TRT is not supported by current evidence as a treatment. The genetic data suggesting a slight increase in osteoarthritis risk with higher testosterone adds a reason for caution. And for rheumatoid arthritis, while the biological rationale is strong, clinical trials testing TRT as an add-on therapy are limited. The practical takeaway is straightforward: if you have arthritis and suspect low testosterone, getting your levels tested is the logical first step. If levels come back low, TRT addresses a real deficiency that likely contributes to both your inflammation and your joint symptoms.